Tyndall Capital Partners L P has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $379 Million distributed in 1 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cyclerion Therapeutics Inc with a value of $379M.

Examining the 13F form we can see an decrease of $148M in the current position value, from $527M to 379M.

Tyndall Capital Partners L P is based out at New York, NY

Below you can find more details about Tyndall Capital Partners L P portfolio as well as his latest detailed transactions.

Portfolio value $379 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 1
  • Current Value $379 Million
  • Prior Value $527 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Tyndall Capital Partners L P Portfolio

Follow Tyndall Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tyndall Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Tyndall Capital Partners L P with notifications on news.